Therapeutic role of taurine as antioxidant in reducing hypertension risks in rats

Aim: The current investigation focused on the therapeutic role of the administration of taurine on hypertensive rats to reduce or cure the hazard effects of hypertension problems. Methodology: This research included 2 experiments; 1st was done to survey the variations that might occur in blood press...

Full description

Bibliographic Details
Main Authors: Marwan A. Ibrahim, Mostafa M. Eraqi, Faiz A. Alfaiz
Format: Article
Language:English
Published: Elsevier 2020-01-01
Series:Heliyon
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2405844020300542
id doaj-914b0768845b405fa9298c5329d156d9
record_format Article
spelling doaj-914b0768845b405fa9298c5329d156d92020-11-25T02:04:56ZengElsevierHeliyon2405-84402020-01-0161e03209Therapeutic role of taurine as antioxidant in reducing hypertension risks in ratsMarwan A. Ibrahim0Mostafa M. Eraqi1Faiz A. Alfaiz2Corresponding author.; Department of Biology, College of Science, Majmaah University, Majmaah, 11952, Saudi ArabiaDepartment of Biology, College of Science, Majmaah University, Majmaah, 11952, Saudi ArabiaDepartment of Biology, College of Science, Majmaah University, Majmaah, 11952, Saudi ArabiaAim: The current investigation focused on the therapeutic role of the administration of taurine on hypertensive rats to reduce or cure the hazard effects of hypertension problems. Methodology: This research included 2 experiments; 1st was done to survey the variations that might occur in blood pressure (BP) of male rats because of the fed 8% NaCl diet for 4 weeks. 2nd experiment, it contains normal control rats', hypertensive rats were served as hypertension recovery group and hypertensive rats were took orally by the help of gastric tube 50 mg taurine/100 g b.wt/day for four weeks and served as taurine group. Results: 1st experimental, clarified a significant elevation in BP, body weight, serum cholesterol, triglycerides, LDL, activities of serum cardiac enzymes, endothelin-1, ADMA, MDA and TNF-α in hypertensive rats' group. On contrary, there is a significant reduction in serum level of TNO and antioxidant enzymes level in relation to the control group. A numerical variation but not statistically significant was happened in HDL in hypertensive rats' group as compared to their matching results in control rats' group. 2nd experimental taurine significantly reduced the BP as compared with hypertensive control. Furthermore, a significant improvement occurred in the mean value of most investigation parameters in hypertensive animal group which treated with taurine. Conclusion: The previous data could be concluded that, there is an obvious amelioration effects of taurine on hypertensive rats by reducing the hazard effects of hypertension problems. The primary mechanisms were discussed according to existing published investigations.http://www.sciencedirect.com/science/article/pii/S2405844020300542BiochemistryRegenerative medicinePublic healthPharmacologyHypertensive ratsTaurine
collection DOAJ
language English
format Article
sources DOAJ
author Marwan A. Ibrahim
Mostafa M. Eraqi
Faiz A. Alfaiz
spellingShingle Marwan A. Ibrahim
Mostafa M. Eraqi
Faiz A. Alfaiz
Therapeutic role of taurine as antioxidant in reducing hypertension risks in rats
Heliyon
Biochemistry
Regenerative medicine
Public health
Pharmacology
Hypertensive rats
Taurine
author_facet Marwan A. Ibrahim
Mostafa M. Eraqi
Faiz A. Alfaiz
author_sort Marwan A. Ibrahim
title Therapeutic role of taurine as antioxidant in reducing hypertension risks in rats
title_short Therapeutic role of taurine as antioxidant in reducing hypertension risks in rats
title_full Therapeutic role of taurine as antioxidant in reducing hypertension risks in rats
title_fullStr Therapeutic role of taurine as antioxidant in reducing hypertension risks in rats
title_full_unstemmed Therapeutic role of taurine as antioxidant in reducing hypertension risks in rats
title_sort therapeutic role of taurine as antioxidant in reducing hypertension risks in rats
publisher Elsevier
series Heliyon
issn 2405-8440
publishDate 2020-01-01
description Aim: The current investigation focused on the therapeutic role of the administration of taurine on hypertensive rats to reduce or cure the hazard effects of hypertension problems. Methodology: This research included 2 experiments; 1st was done to survey the variations that might occur in blood pressure (BP) of male rats because of the fed 8% NaCl diet for 4 weeks. 2nd experiment, it contains normal control rats', hypertensive rats were served as hypertension recovery group and hypertensive rats were took orally by the help of gastric tube 50 mg taurine/100 g b.wt/day for four weeks and served as taurine group. Results: 1st experimental, clarified a significant elevation in BP, body weight, serum cholesterol, triglycerides, LDL, activities of serum cardiac enzymes, endothelin-1, ADMA, MDA and TNF-α in hypertensive rats' group. On contrary, there is a significant reduction in serum level of TNO and antioxidant enzymes level in relation to the control group. A numerical variation but not statistically significant was happened in HDL in hypertensive rats' group as compared to their matching results in control rats' group. 2nd experimental taurine significantly reduced the BP as compared with hypertensive control. Furthermore, a significant improvement occurred in the mean value of most investigation parameters in hypertensive animal group which treated with taurine. Conclusion: The previous data could be concluded that, there is an obvious amelioration effects of taurine on hypertensive rats by reducing the hazard effects of hypertension problems. The primary mechanisms were discussed according to existing published investigations.
topic Biochemistry
Regenerative medicine
Public health
Pharmacology
Hypertensive rats
Taurine
url http://www.sciencedirect.com/science/article/pii/S2405844020300542
work_keys_str_mv AT marwanaibrahim therapeuticroleoftaurineasantioxidantinreducinghypertensionrisksinrats
AT mostafameraqi therapeuticroleoftaurineasantioxidantinreducinghypertensionrisksinrats
AT faizaalfaiz therapeuticroleoftaurineasantioxidantinreducinghypertensionrisksinrats
_version_ 1724940208683614208